We performed a real-life observation of patients with Parkinson disease (PD) who received duodenal levodopa infusion (DLI) to determine which adverse events caused treatment discontinuation and when such events occurred.
Calandrella, D., Romito, L. M. A., Elia, A. E., Del Sorbo, F., Bagella, C., Falsitta,, Albanese, A., Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease, <<NEUROLOGY>>, 2015; 84 (16): 1669-1672. [doi:10.1212/WNL.0000000000001500] [http://hdl.handle.net/10807/66600]
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
Romito, Luigi Michele Antonio;Elia, Antonio Emanuele;Bagella, Caterina;Albanese, Alberto
2015
Abstract
We performed a real-life observation of patients with Parkinson disease (PD) who received duodenal levodopa infusion (DLI) to determine which adverse events caused treatment discontinuation and when such events occurred.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
